Everything we've seen

1. ?Sep 14, 3:20 PMdecisionconsidered

   Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

   STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

2. !Sep 14, 3:20 PMsignalseverity 0.12

   Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

   STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

3. ?Sep 14, 3:20 PMdecisionconsidered

   Agent 5 — Dip Buyer (Evolving) — decide: skip

   STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

4. !Sep 14, 3:20 PMsignalseverity 0.12

   Agent 5 — Dip Buyer (Evolving) — dip_skipped

   STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

5. ?Sep 14, 2:20 PMdecisionconsidered

   Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

   STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

6. !Sep 14, 2:20 PMsignalseverity 0.12

   Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

   STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

7. ?Sep 14, 2:20 PMdecisionconsidered

   Agent 5 — Dip Buyer (Evolving) — decide: skip

   STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

8. !Sep 14, 2:20 PMsignalseverity 0.12

   Agent 5 — Dip Buyer (Evolving) — dip_skipped

   STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

9. ?Sep 14, 1:20 PMdecisionconsidered

   Agent 5 — Dip Buyer (Evolving) — decide: skip

   STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

10. !Sep 14, 1:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

11. ?Sep 14, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

12. !Sep 14, 1:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

13. ?Sep 14, 12:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

14. !Sep 14, 12:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

15. ?Sep 14, 12:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

16. !Sep 14, 12:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

17. ?Sep 14, 11:21 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

18. !Sep 14, 11:21 AMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

19. ?Sep 14, 11:21 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

20. !Sep 14, 11:21 AMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

21. ?Sep 14, 10:21 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

22. !Sep 14, 10:21 AMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

23. ?Sep 14, 10:21 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

24. !Sep 14, 10:21 AMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

25. ?Sep 14, 7:01 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

26. !Sep 14, 7:01 AMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

27. ?Sep 14, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

28. !Sep 14, 7:00 AMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

29. ?Sep 11, 6:04 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

30. !Sep 11, 6:04 PMsignalseverity 0.13

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

31. ?Sep 11, 4:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

32. !Sep 11, 4:20 PMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

33. ?Sep 11, 4:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

34. !Sep 11, 4:20 PMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

35. ?Sep 11, 3:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

36. !Sep 11, 3:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

37. ?Sep 11, 3:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

38. !Sep 11, 3:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

39. ?Sep 11, 2:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

40. !Sep 11, 2:21 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

41. ?Sep 11, 2:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

42. !Sep 11, 2:21 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

43. ?Sep 11, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

44. !Sep 11, 1:20 PMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

45. ?Sep 11, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

46. !Sep 11, 1:20 PMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

47. ?Sep 11, 12:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

48. !Sep 11, 12:21 PMsignalseverity 0.13

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

49. ?Sep 11, 12:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

50. !Sep 11, 12:20 PMsignalseverity 0.13

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

51. ?Sep 10, 4:26 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

52. !Sep 10, 4:26 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

53. ?Sep 10, 4:26 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

54. !Sep 10, 4:26 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

55. ?Sep 9, 4:25 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

56. !Sep 9, 4:25 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STERIS (STE) is a well-established healthcare infrastructure/sterilization company with historically stable fundamentals. The ~11% drop from the 30-day high appears moderate and likely macro/sector-driven rather than company-specific, as the Health Care sector is underperforming SPY on both 5d and 30d bases. However, there are no confirmation signals — no insider purchases, no unusual call flow, no news catalysts — making this purely a passive dip with no identifiable recovery trigger. The 10-Q filed in early August had no quantitative metrics surfaced, leaving fundamental health unconfirmed, and earnings are 55 days away (non-factor). The macro backdrop features elevated 10Y yields (4.78%) and a 5YIFR reading 1.8σ above trend, which is a headwind for rate-sensitive healthcare names.

57. ?Sep 9, 4:25 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

58. !Sep 9, 4:25 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

59. ?Sep 2, 11:10 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.17% today with no attributable headline, suggesting institutional flow rather than retail reaction to news — flow-driven moves can persist. With 275 minutes remaining (roughly 4.5 hours), there is ample session time for continuation. However, the macro context is a mild headwind: the 5-year forward inflation rate (T5YIFR) is running 1.7σ above trend, which typically pressures rate-sensitive and high-multiple healthcare/MedTech names like STE by elevating discount rates. STE is a stable, defensive MedTech name, so it is somewhat insulated from pure rate panic, but elevated inflation expectations do dampen enthusiasm for valuation expansion. No reversal signals are visible, and absence of news is not disqualifying. Balancing the meaningful 2%+ move (real conviction) against the mild macro headwind and no catalyst to amplify the move into the close, this reads as a modest continuation setup — probability just above the action threshold.

60. !Sep 2, 11:10 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    STE is up 2.17% today with no attributable headline, suggesting institutional flow rather than retail reaction to news — flow-driven moves can persist. With 275 minutes remaining (roughly 4.5 hours), there is ample session time for continuation. However, the macro context is a mild headwind: the 5-year forward inflation rate (T5YIFR) is running 1.7σ above trend, which typically pressures rate-sensitive and high-multiple healthcare/MedTech names like STE by elevating discount rates. STE is a stable, defensive MedTech name, so it is somewhat insulated from pure rate panic, but elevated inflation expectations do dampen enthusiasm for valuation expansion. No reversal signals are visible, and absence of news is not disqualifying. Balancing the meaningful 2%+ move (real conviction) against the mild macro headwind and no catalyst to amplify the move into the close, this reads as a modest continuation setup — probability just above the action threshold.

61. ?Aug 6, 6:04 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [exhaustion] The 20-day PV path shows a strong accumulation leg from the low-volume cluster around $210–$214 (July 22–24, with ADV-like volumes of 454K–691K) that broke up sharply on July 28–29 (closes $230.34 and $234.83 on volumes of 873K and 923K respectively), consistent with a genuine cluster_break_up. However, today's bar on 2026-08-06 introduces a material warning: volume exploded to 1.9M — a z-score of 8.25 versus the trailing 20-day mean of 727K (roughly 2.6× the next heaviest day in the window) — yet price only moved -0.49% to $231.56, well below the July 29 peak of $234.83. In the SIR 2-D framework, this combination of a price extreme (top of the recent range) met by an unprecedented volume spike on a down day is the textbook exhaustion signature: the path has lurched far right on the X-axis without advancing on the Y-axis, suggesting climactic selling or distribution absorbed by thin demand. Checking the bearish-pattern confirmation criteria: (1) price IS near a multi-week high AND volume is ~2.6× ADV ✓; (2) the most recent 3-session sub-path (Aug 4–6: +0.09%, -0.06%, -0.49%) shows net negative price movement on volumes of 911K, 923K, 1.9M — expanding volume with net price deterioration ✓. Two of the three criteria are met, so the exhaustion label stands even under the asymmetric bull-regime burden of proof. Risks: This read is invalidated if the next 1–2 sessions show STE recovering above $234 (the July 29 high) on sustained but not panicked volume (~800K–1.1M), which would reframe today's spike as a shakeout/absorption day rather than a climax top. Additionally, if the macro environment shifts to a confirmed broad risk-on rally (e.g., VIX collapses, broad index breaks to new highs), the exhaustion signal would need multi-session confirmation before acting on the bearish read.

62. ?Aug 6, 9:46 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is down ~4.92% intraday with no attributable headline, suggesting institutional-driven selling or sector rotation rather than a news-driven spike that might quickly reverse. A move of this magnitude reflects real conviction from sellers with size. The macro context shows 5-year inflation expectations (T5YIE) running 1.9σ below trend, which is modestly negative for healthcare/medtech names like STE (a medical sterilization/equipment company) as lower inflation expectations can compress pricing power narratives and reduce risk appetite in defensive growth names. With 360 minutes remaining — essentially a full session still ahead — there is ample time for continuation. No reversal catalyst is evident (no news, no macro tailwind for the sector). The absence of a bounce catalyst and the clean directional move favor modest continuation. However, STE is a quality defensive name and a ~5% drop without news could attract value buyers into the close, limiting conviction. Probability set at 0.54 — lean continuation but modest, no clear amplifying catalyst.

63. ?Jul 16, 2:36 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 3.64% intraday with no attributable headline — suggesting institutional flow or a catalyst not yet publicly disclosed. A move of this magnitude represents real conviction and is itself meaningful evidence of buying pressure. However, several factors temper enthusiasm: (1) 70 minutes remaining is enough time for continuation but also enough for a fade, especially if the move was driven by a single large order that has now been filled; (2) no news to anchor continued buying interest or attract momentum traders; (3) the macro backdrop (T5YIE 1.6σ below trend, indicating subdued inflation expectations) is slightly supportive of defensive/healthcare-adjacent names like STE (sterile processing/medical devices), but this is a weak tailwind at best; (4) the move is already at the upper bound of the 2-5% 'meaningful' range, meaning the easy gains may already be captured and late buyers face elevated risk of a partial reversal into the close. Net assessment: mild continuation bias. The bounded risk profile (1.5% stop, 3% target, hard EOD flatten) makes this marginally worth taking, but confidence is low.

64. ?Jul 15, 1:15 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.57% intraday with 150 minutes remaining, representing meaningful buying flow and conviction. No headline catalyst is identified, but absence of news does not disqualify momentum — institutional flows or sector rotation can drive sustained moves without explicit news. STE is a medical device/healthcare name, which falls into defensive/healthcare territory. The macro context shows T10Y2Y at 1.9σ below trend (flat/modestly inverted curve), which tends to be supportive of defensives on a relative basis. With 150 minutes remaining, there is ample time for continuation. No reversal signals or fade patterns are noted. The move is near the lower bound of the 2-5% 'meaningful' range, so while real, it is not an extreme gap that typically attracts aggressive faders. No volume concern is flagged. Overall, the balance of evidence mildly favors continuation into the close, but without a clear catalyst or volume confirmation this is a modest-conviction setup, placing probability in the 0.50-0.60 range.

65. ?Jul 14, 12:30 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is down 3.46% intraday, a meaningful move reflecting real selling pressure. No headlines are available to explain the move, but absence of news is not a disqualifier — large moves often precede public catalysts or reflect institutional repositioning. With 195 minutes remaining, there is ample time for continuation. The macro context (T10Y2Y at 1.9σ below trend, a flattening/slightly inverted curve) is modestly supportive of defensive names like STE (medical device/sterilization), which could argue for stabilization or reversal rather than further selling. However, defensives can also get hit when risk-off flows rotate into cash or when sector-specific pressure is at play. Without a clear reversal signal (e.g., price reclaiming a key level, volume drying up) and given the magnitude of the move already in place, the path of least resistance remains slightly lower. The curve context is a mild headwind to continuation but not decisive. Probability sits marginally above 0.5 — ordinary momentum with no strong reason to fade the move outright, but no high-conviction continuation catalyst either. Tight stops at -1.5% from entry bound the downside risk.

66. ?Jul 9, 6:04 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — buy

    [not executed — reserve_floor_or_cash] [cluster_break_up] The 20-day PV path tells a coherent two-phase story. From 2026-06-10 through 2026-07-08, STE oscillated in a rough $199–$218 band on mostly subdued volume (median daily volume well under 900K, with several sessions — 2026-07-02 at 525K, 2026-07-06 at 621K, 2026-07-07 at 567K, 2026-07-08 at 605K — representing the tightest, lowest-volume cluster of the window near the $209–$215 zone). Today, 2026-07-09, price broke back above that recent tight cluster to close at $216.00 (+3.11%) on 1.3M shares — a volume z-score of +1.66 and roughly 53% above the 20-day ADV of 849K — the largest single-session volume since the 1.6M spike on 2026-06-18. Critically, the prior four sessions (2026-07-02–2026-07-08) formed a low-volume, compressed price shelf between ~$209 and $215; today's bar breaks cleanly above that shelf on a material volume expansion, satisfying the SIR cluster-break-up criterion of fresh demand absorbing the float at a higher price level. Risks: A failure to hold above the $213–$215 shelf on any subsequent pullback — especially on expanding down-day volume — would negate the breakout and suggest the 2026-07-09 bar was a one-day exhaustion spike rather than the start of sustained accumulation. Absence of follow-through volume over the next 2–3 sessions (a reversion toward the 20-day ADV of ~849K or below, with price fading back under $213) would also invalidate the read.

67. ?Jul 9, 3:16 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.72% intraday with no attributable headline, suggesting institutional flow or a delayed reaction to a catalyst. However, with only 30 minutes remaining until the forced close, the time window severely limits further upside potential. The move has already captured most of its intraday range, and late-session profit-taking or mean reversion in the absence of a clear catalyst is a real risk. The macro context (T10Y2Y at 2.1σ below trend, bear-flattening signals) is mildly favorable for defensives like STE (medical/sterilization), which could provide modest tailwind, but this is a weak signal. The combination of very limited time remaining, no news catalyst to sustain buying pressure, and a move that has already extended 2.72% leads me to marginally below the continuation threshold. The risk/reward does not favor initiating a position this close to EOD flatten.

68. ?Jul 9, 2:15 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.49% today with no identifiable headline catalyst, suggesting this is institutional flow-driven rather than news-driven. STE is a healthcare/medtech name (Steris plc), which falls into the defensive sector category. The macro context shows T10Y2Y at 2.1σ below trend, indicating a flattening/slightly inverted curve environment — generally supportive of defensives. With 90 minutes remaining, there is reasonable time for continuation but not enough to be aggressive. The absence of news is neutral per framework guidance. The move size (2.49%) is meaningful and represents real conviction. However, there is no strong confirmation signal (no volume data flagged as above average, no clear sector catalyst), so this sits in the ordinary momentum bucket. Modest continuation probability assigned — lean long but without high conviction.

69. ?Jul 8, 12:05 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is down 2.07% intraday with no attributable headline — this represents real selling flow, likely institutional, which is meaningful on its own. The macro context shows a flattening yield curve (T10Y2Y at 2.0σ below trend), which tends to favor defensive sectors like healthcare/medtech where STE operates, but this dynamic is ambiguous: bear-flattening can pressure high-multiple defensives if it signals risk-off rotation into cash rather than into the sector. With 220 minutes remaining there is ample time for continuation, which is a positive for staying with the trend. However, without a clear catalyst (no headlines), the move could be reversion-prone, and STE as a medtech/sterilization name doesn't have obvious macro tailwinds from today's rate shape. The absence of news and the moderate (not extreme) move size keep this a borderline read. Overall, the base rate for intraday momentum continuation is slightly better than coin-flip with meaningful size flow and time remaining, so a marginal continuation call is warranted.

70. ?Jun 30, 10:20 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is down 2.69% intraday with no attributable headline, suggesting this is flow/technical driven rather than news-driven. The move is meaningful in magnitude and represents real selling conviction. Macro context shows 10Y inflation expectations (T10YIE) printing 1.7σ below trend, which favors long-duration assets and would generally be a mild tailwind for defensive/healthcare names like STE — this slightly opposes continuation of the downside move. However, absence of a bullish catalyst and the fact that a 2.69% move has already occurred without reversal suggests the selling flow has not been absorbed. With 325 minutes remaining (over 5 hours, essentially the full remaining session), there is ample time for continuation. No reversal pattern is indicated. Balancing the mild macro headwind against the continuation of an already-established intraday trend with significant time remaining, I lean modestly toward continuation of the downside move, but without strong conviction given the macro backdrop slightly opposing it.

71. ?Jun 26, 3:11 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.37% intraday with no attributable headline, suggesting idiosyncratic flow or sector rotation. However, several factors weigh against continuation into the close: (1) Only 35 minutes remain until the forced 3:45 PM cutoff, leaving very limited runway for additional gains to reach the +3% target from current levels — the stock would need to add another ~0.63% in a short window. (2) The macro context shows T10YIE at 1.9σ below trend, indicating compressed inflation expectations, which is modestly supportive for long-duration sensitive sectors but STE (Steris, healthcare/medical devices) is not a primary beneficiary of that dynamic. (3) No news catalyst to sustain momentum or attract fresh buyers into the close. (4) With a 2.37% move already in, late-session profit-taking is a realistic risk, particularly absent a clear catalyst. The setup is borderline — momentum exists, but the combination of limited time, no catalyst, and a non-ideal macro alignment tips the probability just below the 0.5 trigger threshold. Declining to enter.

72. ?Jun 24, 10:20 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.05% intraday with no headline catalyst, suggesting quiet but real institutional flow rather than news-driven spike. The move is meaningful but not extreme, leaving room for continuation. Macro context shows 10Y inflation expectations (T10YIE) running 2.0σ below trend, which is modestly supportive for defensive/healthcare equipment names like Steris (lower real rate pressure, flight to quality bias). No reversal signal is evident from the data provided. However, with 325 minutes remaining (roughly full afternoon session), time is ample but the absence of any news or sector catalyst limits conviction. The macro backdrop provides mild tailwind but not a strong one. No evidence of fade or reversal pattern. This is a borderline ordinary momentum setup — no strong reason to expect a fade, so probability resolves slightly above 0.5 per system guidance.

73. ?Jun 4, 11:10 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.06% today with no attributable headline, suggesting organic institutional flow or sector rotation into defensive/healthcare names. The macro context shows a flattening yield curve (T10Y2Y at 2.1σ below trend), which tends to favor defensive sectors like healthcare/medtech where STE operates — this is a mild tailwind. With 275 minutes remaining (roughly 4.5 hours), there is ample time for the move to extend. However, the absence of a catalyst means the move could simply be a single-session repositioning that fades as the day progresses. The magnitude (2.06%) is real but not extreme, sitting at the lower bound of the 2-5% 'meaningful flow' range. No reversal pattern is evident from the data provided. On balance, the combination of defensive sector macro support, sufficient time remaining, and no fade signal tips the probability modestly above the 0.5 threshold, but without a clear catalyst or volume confirmation signal this does not qualify as a high-conviction continuation setup.

74. ?May 21, 3:15 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 1.59% today, a modest but real move with no attributable headline catalyst. With only 30 minutes remaining until the forced close, there is very limited time for the move to extend meaningfully. The macro context shows elevated 10-year inflation expectations (T10YIE 1.7σ above trend), which creates a headwind for long-duration sensitive sectors — STE as a medical device/sterilization company carries some duration sensitivity in its valuation. The absence of news means we cannot confirm institutional conviction behind the move. At this late stage of the session, the risk of end-of-day profit-taking or mean reversion in a low-catalyst environment slightly outweighs continuation. The time constraint is the primary reason this falls just below the 0.5 threshold rather than sitting in the 0.5-0.55 range it would otherwise occupy.

75. ?May 15, 9:01 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.31% intraday with no attributable headline, suggesting real institutional flow rather than a news-driven spike that fades. The move is meaningful but not extreme — sitting in the 2-3% range where momentum often has room to extend. However, several factors temper conviction: (1) 404 minutes remaining is actually a very large number — well over 6 hours — suggesting this is early in the session, which means there is ample time for both continuation AND reversal; (2) the macro backdrop (T5YIE at 2.7, 2.5σ above trend) signals elevated inflation expectations, which is modestly negative for medical device/healthcare services names like STERIS as it implies higher discount rates and potential cost pressures — not a tailwind for the sector; (3) no news catalyst means we cannot confirm what is driving the move, making it harder to assess durability. On balance, the initial momentum and size of move provide a modest edge toward continuation, but the macro headwind and absence of a confirmed catalyst prevent a high-confidence read. Probability sits just above 0.5 — a marginal continuation call.